Skip to content
Parakho

Mishra Dhatu Nigam LtdQ4 FY26 earnings call

All quarters

Summary generated by AI from the official transcript Mishra Dhatu Nigam Ltd filed with BSE on 06 Jun 2026. Every statement cites a verbatim quote from that document — open any citation to read it. This is a record of what management said, not a recommendation. How we check these summaries

The short read

MIDHANI reported its highest-ever quarterly turnover of INR552.7 crores for Q4 FY26, up 34.63% year-on-year, with PAT of INR77.75 crores, up 38.49%. For the full year, the company achieved turnover of INR1,208.63 crores, up 12.52%, and PAT of INR130.79 crores, up 18.82%, with an order book of INR2,290 crores as of April 1, 2026. Management highlighted achievements including record Titanium production, a new metal bank initiative for critical raw materials, NADCAP certification for heat treatment, and a new aerospace fastener manufacturing facility.

Numbers mentioned

Quarterly turnover: INR552.7 crores (Q4 FY26)

p. 3
we have achieved the highest ever quarterly turnover of INR552.7 crores, registering a growth of 34.63% against a turnover of INR410.56 crores recorded in the corresponding quarter in the previous year

Dr. S.V.S. Narayana Murty, page 3 of the filed PDF · View the filing

Value of production: INR392.19 crores (Q4 FY26)

p. 3
our value of production during fourth quarter '25-'26 stood at INR392.19 crores, registering a growth of 19.15% against value of production of INR329.19 crores recorded in the corresponding quarter in the previous year

Dr. S.V.S. Narayana Murty, page 3 of the filed PDF · View the filing

PBT: INR107 crores (Q4 FY26)

p. 3
Our PBT during fourth quarter stood at INR107 crores, with a growth of 38.67% against PBT of INR77.16 crores in the previous quarter

Dr. S.V.S. Narayana Murty, page 3 of the filed PDF · View the filing

PAT: INR77.75 crores (Q4 FY26)

p. 3
PAT in the fourth quarter stood at INR77.75 crores, with a growth of 38.49% against PAT of INR56.14 crores recorded in the previous quarter of this previous year

Dr. S.V.S. Narayana Murty, page 3 of the filed PDF · View the filing

Annual turnover: INR1,208.63 crores (FY26)

p. 3
The company achieved the highest ever turnover of INR1,208.63 crores, registering a growth of 12.52% against the turnover of INR1,074.1 crores during the previous financial year, '24, '25

Dr. S.V.S. Narayana Murty, page 3 of the filed PDF · View the filing

Order book: INR2,290 crores (as on April 1, 2026)

p. 3
And the order book position of the company as on April 1, 2026 is INR2,290 crores

Dr. S.V.S. Narayana Murty, page 3 of the filed PDF · View the filing

Annual PAT: INR130.79 crores (FY26)

p. 3
our PAT for FY '25-'26 was INR130.79 crores with a growth of 18.82% against INR110.07 crores recorded in the previous financial year '24-'25

Dr. S.V.S. Narayana Murty, page 3 of the filed PDF · View the filing

Titanium production: 700 tons (FY26)

p. 3
So we have produced 700 tons of Titanium, almost doubling from previous years

Dr. S.V.S. Narayana Murty, page 3 of the filed PDF · View the filing

Titanium order book: more than INR660 crores

p. 6
currently, we have about more than INR660 crores worth of Titanium orders and we are likely to get more

Dr. S.V.S. Narayana Murty, page 6 of the filed PDF · View the filing

Open order book: INR2,249 crores

p. 7
currently, our open order book is INR2,249 crores, maybe INR2,250 crores

Dr. S.V.S. Narayana Murty, page 7 of the filed PDF · View the filing

Export turnover: INR85 crores (FY26)

p. 8
This year, INR'25-'26, we have done INR85 crores, and we are expecting at least INR100 crores we'll be doing in this financial year

Padavittan Babu, page 8 of the filed PDF · View the filing

Defence share of open order book: 79%

p. 8
The Defence is about 79% of the total order book

Dr. S.V.S. Narayana Murty, page 8 of the filed PDF · View the filing

Turnover from Space: INR93 crores (FY26)

p. 9
So the turnover, the '25-'26, space is about INR93 crores

Padavittan Babu, page 9 of the filed PDF · View the filing

Turnover from Defence: INR301 crores (FY26)

p. 9
About INR301 crores from defense

Padavittan Babu, page 9 of the filed PDF · View the filing

Turnover from PSUs: INR603 crores (FY26)

p. 9
PSUs are INR603 crores, public sector enterprises

Padavittan Babu, page 9 of the filed PDF · View the filing

Investment cast business: about INR10 crores

p. 9
So currently, our investment cast business is about INR10 crores

Dr. S.V.S. Narayana Murty, page 9 of the filed PDF · View the filing

ABHED jacket order value: about INR1 crore

p. 12
It was about INR1 crore

Dr. S.V.S. Narayana Murty, page 12 of the filed PDF · View the filing

What management said it would do

A record of statements made on the call, in the words management used. Parakho does not forecast, endorse or assess them, and their presence here is not a view on whether they will happen.

Revenue growth — 15% to 20% · FY27 and next few years

stated conditionally by Dr. S.V.S. Narayana Murty

p. 7
One thing is we had this year, maybe 12%, we have exceeded the top line growth, 12% to 15%, we should be able to maintain. Our target will be 20%. But it all depends on the supply chain constraints of raw materials.

Dr. S.V.S. Narayana Murty, page 7 of the filed PDF · View the filing

EBITDA margin — 23% to 25%

stated as an aspiration by Padavittan Babu

p. 7
It will be slightly up by 23% to 25% we can expect. When the revenue goes up by 20%, obviously, the margins will increase, maybe around we can expect 23% to 25% between EBITDA.

Padavittan Babu, page 7 of the filed PDF · View the filing

Order booking — INR1,500 crores · FY27

stated as an aspiration by Dr. S.V.S. Narayana Murty Export order book crcroreseframe renull

p. 7
So maybe we will be able to book about INR1,500 crores worth of orders in this financial year, FY '26-'27.

Dr. S.V.S. Narayana Murty Export order book crcroreseframe renull, page 7 of the filed PDF · View the filing

Generated by claude-sonnet-5. Source: the transcript as filed with BSE. We link to the exchange's copy; we do not host transcripts. Parakho is a data and screening tool, not an investment adviser — nothing here is a recommendation to buy, sell or hold.